Reuters logo
BRIEF-Biotec's Woulgan application to be reconsidered by UK Drug Tariff
September 12, 2017 / 12:07 PM / 2 months ago

BRIEF-Biotec's Woulgan application to be reconsidered by UK Drug Tariff

Sept 12 (Reuters) - BIOTEC PHARMACON ASA:

* ‍BIOTEC BETAGLUCANS HAS RECEIVED POSITIVE FEEDBACK FROM UK DRUG TARIFF APPEAL PANEL​

* UK DRUG TARIFF APPEAL PANEL WILL RECONSIDER BIOTEC‘S APPLICATION FOR REIMBURSEMENT OF WOULGAN​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below